[1-(2,3-Dihydro-benzo[1,4]dioxine-2-carbonyl)-piperidin-2-ylMethyl]-carbaMic acid tert-butyl ester
![]() |
- $400 - $469
- Product name: [1-(2,3-Dihydro-benzo[1,4]dioxine-2-carbonyl)-piperidin-2-ylMethyl]-carbaMic acid tert-butyl ester
- CAS: 1353948-19-2
- MF: C20H28N2O5
- MW: 376.45
- EINECS:
- MDL Number:
- Synonyms:[1-(2,3-Dihydro-benzo[1,4]dioxine-2-carbonyl)-piperidin-2-ylMethyl]-carbaMic acid tert-butyl ester;tert-Butyl ((1-(2,3-dihydrobenzo[b][1,4]dioxine-2-carbonyl)piperidin-2-yl)Methyl)carbaMate;Carbamic acid, N-[[1-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-2-piperidinyl]methyl]-, 1,1-dimethylethyl ester
3 prices
Selected condition:
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 1g
- ManufacturerAlichem
- Product number1353948192
- Product descriptiontert-Butyl((1-(2,3-dihydrobenzo[b][1,4]dioxine-2-carbonyl)piperidin-2-yl)methyl)carbamate
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM156072
- Product descriptiontert-Butyl((1-(2,3-dihydrobenzo[b][1,4]dioxine-2-carbonyl)piperidin-2-yl)methyl)carbamate 95%
- Packaging1g
- Price$439
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11286517
- Product descriptiontert-Butyl((1-(2,3-dihydrobenzo[b][1,4]dioxine-2-carbonyl)piperidin-2-yl)methyl)carbamate 95+%
- Packaging1g
- Price$469
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1353948192 | tert-Butyl((1-(2,3-dihydrobenzo[b][1,4]dioxine-2-carbonyl)piperidin-2-yl)methyl)carbamate | 1g | $400 | 2021-12-16 | Buy |
Chemenu | CM156072 | tert-Butyl((1-(2,3-dihydrobenzo[b][1,4]dioxine-2-carbonyl)piperidin-2-yl)methyl)carbamate 95% | 1g | $439 | 2021-12-16 | Buy |
Crysdot | CD11286517 | tert-Butyl((1-(2,3-dihydrobenzo[b][1,4]dioxine-2-carbonyl)piperidin-2-yl)methyl)carbamate 95+% | 1g | $469 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|